AI Overview Novo Nordisk is discontinuing Levemir (both FlexPen and Penfill cartridges) due to global usage trends, portfolio consolidation, and manufacturing constraints, as it is an older insulin. The manufacturer has confirmed the decision is not related to any safety or quality issues.UK supply is expected to be phased out completely by the end of 2026. Because Levemir is being phased out, healthcare professionals are actively advising patients to transition to suitable alternative basal insulins as soon as possible.
Found when I googled.